Adjunct VR Pain Management in Acute Brain Injury
Adjunct Virtual Reality Pain Management in Acute Brain Injury
2 other identifiers
interventional
60
1 country
2
Brief Summary
Severe and refractory pain after acute injury is a known-risk factor for chronic opioid use disorder. In this study, the investigators will use Virtual Reality (VR) immersion as a non-pharmacological adjunct to treat pain associated with acute traumatic injuries, including traumatic brain injury. The investigators hypothesize that VR therapy will decrease pain and reduce opioid use in patients with acute traumatic injuries, including TBI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2020
CompletedFirst Posted
Study publicly available on registry
April 22, 2020
CompletedStudy Start
First participant enrolled
September 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedResults Posted
Study results publicly available
April 24, 2023
CompletedApril 24, 2023
April 1, 2023
1.3 years
April 19, 2020
January 27, 2023
April 1, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Pain Score
Pre- vs. Post-Intervention Ratings on Numeric Pain Rating Scale. Numeric Pain Rating scale range is from 0 (no pain) -10 (severe pain)
Pre- and Post-Intervention (approximately 30 minutes)
Secondary Outcomes (1)
Opioid Administration
4 hours post-intervention vs. 4 hours pre-intervention
Other Outcomes (5)
Change in Nausea
Pre- and Post-Intervention (approximately 30 minutes)
Change in Anxiety
Pre- and Post-Intervention (approximately 30 minutes)
Change Heart Rate Variability
Mean NN from last 15 minutes of each intervention compared to mean NN from 15 minutes immediately prior to intervention
- +2 more other outcomes
Study Arms (1)
All patients
EXPERIMENTALAll patients were intended to engage in three different 20-30 min sessions run by research coordinators and spaced a minimum of 4 hours apart to allow for washout of effects, including 1) a commercially available, immersive VR environment, theBlu (WEVR, Inc, Venice, California, USA) delivered via Oculus Rift (Oculus VR, Irvine, California, USA) headset (VR Blu), 2) a non-immersive two-dimensional mimic delivered via a tablet computer (Tablet Blu), and 3) a VR control session delivered via a content-less Oculus Rift headset (VR Blank). The three sessions were run by research coordinators and spaced a minimum of 4 hours apart. The intervention order was counterbalanced using a randomized sequence generator.
Interventions
20-30 minute session of virtual reality immersive content.
20-30 minute session of tablet-based content that mimics the content from virtual reality sessions.
20-30 minutes session using head mounted display to reduce light and sound.
Eligibility Criteria
You may qualify if:
- Diagnosis of Traumatic Injury (including but not limited to traumatic brain injury)
- Age greater than or equal to 18 years-old
- Endorsing at least moderate pain as defined by documentation of at least one numeric rating pain scale score of 3 or more in the last 24 hours.
- Glasgow Coma Scale of 15
- Expected to stay in the hospital for at least 12 hours after enrollment
You may not qualify if:
- Seizure prior to enrollment
- Pregnancy
- non-English speaking
- Known intolerance of Virtual Reality
- Patient unable to consent for themselves
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
R Adams Cowley Shock Trauma Center
Baltimore, Maryland, 21201, United States
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
Related Publications (2)
Morris NA, Wang Y, Felix RB, Rao A, Arnold S, Khalid M, Armahizer MJ, Murthi SB, Colloca L. Adjunctive virtual reality pain relief after traumatic injury: a proof-of-concept within-person randomized trial. Pain. 2023 Sep 1;164(9):2122-2129. doi: 10.1097/j.pain.0000000000002914. Epub 2023 Apr 19.
PMID: 37079851DERIVEDFelix RB, Rao A, Khalid M, Wang Y, Colloca L, Murthi SB, Morris NA. Adjunctive virtual reality pain relief following traumatic injury: protocol for a randomised within-subjects clinical trial. BMJ Open. 2021 Nov 30;11(11):e056030. doi: 10.1136/bmjopen-2021-056030.
PMID: 34848527DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Very few patients with TBI met inclusion criteria. The intervals between conditions were quite short to improve feasibility of study completion based on brief anticipated length of stay. This limited our ability to evaluate effects on opioid use and duration of VR intervention effect. The sample size limited our ability to account for multiple comparisons.
Results Point of Contact
- Title
- Dr. Nicholas Morris
- Organization
- University of Maryland School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Nicholas A Morris, M.D.
University of Maryland, Baltimore
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Interventions will take place in patient rooms with curtain pulled and sign to mask active intervention vs. control intervention from care providers.
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Neurology
Study Record Dates
First Submitted
April 19, 2020
First Posted
April 22, 2020
Study Start
September 5, 2020
Primary Completion
January 7, 2022
Study Completion
April 30, 2022
Last Updated
April 24, 2023
Results First Posted
April 24, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share